Stavra A. Xanthakos

ORCID: 0000-0001-9179-005X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Bariatric Surgery and Outcomes
  • Liver Disease and Transplantation
  • Diet and metabolism studies
  • Pancreatitis Pathology and Treatment
  • Obesity, Physical Activity, Diet
  • Liver Diseases and Immunity
  • Obesity and Health Practices
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Per- and polyfluoroalkyl substances research
  • Diabetes and associated disorders
  • Nutrition and Health in Aging
  • Birth, Development, and Health
  • Pediatric Hepatobiliary Diseases and Treatments
  • Folate and B Vitamins Research
  • Lipid metabolism and disorders
  • Gastroesophageal reflux and treatments
  • Nutritional Studies and Diet
  • Endoplasmic Reticulum Stress and Disease
  • Food Security and Health in Diverse Populations
  • Alcohol Consumption and Health Effects
  • Body Contouring and Surgery
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Disease and Adiposity

Cincinnati Children's Hospital Medical Center
2016-2025

University of Cincinnati Medical Center
2010-2025

University of Cincinnati
2016-2025

The Medical Center of Aurora
2023-2024

Fairfield Hospital
2023

Cincinnati Sportsmedicine and Orthopaedic Center
2010-2023

University of Antwerp
2023

City University of New York
2023

Yonsei University
2023

Princess Alexandra Hospital
2023

The principal limitations of the terms NAFLD and NASH are reliance on exclusionary confounder use potentially stigmatising language. This study set out to determine if content experts patient advocates were in favor a change nomenclature and/or definition. A modified Delphi process was led by three large pan-national liver associations. consensus defined priori as supermajority (67%) vote. An independent committee external made final recommendation acronym its diagnostic criteria. total 236...

10.1097/hep.0000000000000520 article EN cc-by-nc-nd Hepatology 2023-06-22

ABSTRACT Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent chronic that occurs in the setting of insulin resistance and increased adiposity. It has rapidly evolved into most common seen pediatric population management challenge for general practitioners, subspecialists, health systems. In this guideline, expert committee on NAFLD reviewed summarized available literature, formulating recommendations to guide screening clinical care children with NAFLD.

10.1097/mpg.0000000000001482 article EN Journal of Pediatric Gastroenterology and Nutrition 2016-11-30

Bariatric surgery is increasingly considered for the treatment of adolescents with severe obesity, but few prospective adolescent-specific studies examining efficacy and safety weight-loss are available to support clinical decision making.

10.1056/nejmoa1506699 article EN New England Journal of Medicine 2015-11-06

Abstract Diets high in saturated fat and fructose have been implicated the development of obesity nonalcoholic steatohepatitis (NASH) humans. We hypothesized that mice exposed to a similar diet would develop NASH with fibrosis associated increased hepatic oxidative stress be further reflected by plasma levels respiratory chain component, oxidized coenzyme Q9 (oxCoQ9). Adult male C57Bl/6 were randomly assigned chow, high-fat (HF), or high-carbohydrate (HFHC) diets for 16 weeks. The chow HF...

10.1002/hep.23797 article EN Hepatology 2010-06-11

Bariatric surgery results in weight loss and health improvements adults adolescents. However, whether outcomes differ according to the age of patient at time is unclear.We evaluated effects Roux-en-Y gastric bypass a cohort adolescents (161 patients enrolled from 2006 through 2012) (396 2009). The two cohorts were participants related but independent studies. Linear mixed Poisson models used compare with regard coexisting conditions between 5 years after surgery. rates death subsequent...

10.1056/nejmoa1813909 article EN New England Journal of Medicine 2019-05-16

<h3>Importance</h3> Severe obesity in childhood is a major health problem with few effective treatments. Weight-loss surgery (WLS) being used to treat severely obese adolescents, although very limited data regarding surgical safety for currently used, minimally invasive procedures. <h3>Objective</h3> To assess the preoperative clinical characteristics and perioperative outcomes of adolescents undergoing WLS. <h3>Design, Setting, Participants</h3> This prospective, multisite observational...

10.1001/jamapediatrics.2013.4296 article EN JAMA Pediatrics 2013-11-04

Inflammation plays a central pathogenic role in the pernicious metabolic and end-organ sequelae of obesity. Among these sequelae, nonalcoholic fatty liver disease (NAFLD) has become most common chronic developed world. The twinned observations that obesity is associated with increased activation interleukin (IL)-17 axis this can regulate damage diverse contexts prompted us to address IL-17RA signaling progression NAFLD. We further examined whether microbe-driven IL-17A regulated NAFLD...

10.1002/hep.26746 article EN cc-by-nc Hepatology 2013-10-12

<h3>Importance</h3> Nonalcoholic fatty liver disease (NAFLD) is a major chronic in children the United States and associated with insulin resistance. In adults, NAFLD also type 2 diabetes. To our knowledge, prevalence of diabetes unknown. <h3>Objective</h3> determine prediabetes assess as risk factors for nonalcoholic steatohepatitis (NASH). <h3>Design, Setting, Participants</h3> This was multicenter, cross-sectional study at 12 pediatric clinical centers across participating National...

10.1001/jamapediatrics.2016.1971 article EN JAMA Pediatrics 2016-08-01

Nonalcoholic fatty liver disease (NAFLD) may have distinct histological features in children and adults, but to date limited data are available on the spectrum significance of lesions pediatric patients. We conducted a multicenter study with well-characterized, biopsy-proven NAFLD (1) assess presence constellation (2) identify clinical laboratory predictors severity. One hundred thirty seen from 1995 2007 five centers United States Canada were studied. Clinical collected. Slides stained...

10.1002/hep.23133 article EN Hepatology 2009-06-19

Background Non-alcoholic steatohepatitis (NASH) and resultant liver fibrosis is a major health problem without approved pharmacotherapy. Pre-clinical results of GR-MD-02, galectin-3 inhibitor, suggested potential efficacy in NASH with advanced fibrosis/cirrhosis prompted initiation clinical development programme fibrosis. Aim To evaluate the safety, pharmacokinetics exploratory pharmacodynamic markers GR-MD-02 subjects having bridging Methods The GT-020 study was first-in-human, sequential...

10.1111/apt.13816 article EN Alimentary Pharmacology & Therapeutics 2016-10-24

Non-alcoholic fatty liver disease (NAFLD) is a common chronic illness with genetically heterogeneous background that can be accompanied by considerable morbidity and attendant health care costs. The pathogenesis progression of NAFLD complex many unanswered questions. We conducted genome-wide association studies (GWASs) using both adult pediatric participants from the Electronic Medical Records Genomics (eMERGE) Network to identify novel genetic contributors this condition.First, natural...

10.1186/s12916-019-1364-z article EN cc-by BMC Medicine 2019-07-17
Jeffrey B. Schwimmer Joel E. Lavine Laura Wilson Brent A. Neuschwander‐Tetri Stavra A. Xanthakos and 95 more Rohit Kohli Sarah E. Barlow Miriam B. Vos Saul J. Karpen Jean P. Molleston Peter F. Whitington Philip Rosenthal Ajay K. Jain Karen F. Murray Elizabeth M. Brunt David E. Kleiner Mark L. Van Natta Jeanne M. Clark James Tonascia Edward Doo Stephanie H. Abrams Sarah E. Barlow Ryan Himes Rajesh Krisnamurthy Leanel Maldonado Rory Mahabir Kimberlee Bernstein Kristin Bramlage Kim M. Cecil Stephanie DeVore Rohit Kohli Kathleen D. Lake Daniel J. Podberesky Alexander J. Towbin Stavra A. Xanthakos Gerald Behr Joel E. Lavine Jay H. Lefkowitch Ali Mencin Elena Reynoso Adina Alazraki Rebecca Cleeton Saul J. Karpen Jessica Cruz Muños Nicholas Raviele Miriam B. Vos Molly Bozic Oscar W. Cummings Ann Klipsch Jean P. Molleston Sarah Munson Kumar Sandrasegaran Girish Subbarao Kimberly Kafka Ann Scheimann Katie Amsden Mark Fishbein E. OG. Kirwan Saeed Mohammad Cynthia K. Rigsby Lisa Sharda Peter F. Whitington Sarah E. Barlow Jose Derdoy Ajay K. Jain Debra King Pat Osmack Joan Siegner Susan D. Stewart Susan Torretta Kristina Wriston Susan S. Baker Lixin Zhu Jonathon Africa Jorge Angeles Sandra Gómez‐Arroyo Hannah I. Awai Cynthia Behling Craig Bross Janis Durelle Michael S. Middleton Kimberly P. Newton Melissa Paiz Jennifer Sanford Jeffrey B. Schwimmer Claude B. Sirlin Patricia Ugalde‐Nicalo Mariana Dominguez Villarreal Bradley E. Aouizerat Jesse Courtier Linda D. Ferrell Shannon Fleck Ryan M. Gill Camille Langlois Emily R. Perito Philip Rosenthal Patrika Tsai Kara Cooper Simon Horslen Evelyn Hsu

10.1053/j.gastro.2016.08.027 article EN Gastroenterology 2016-08-31
Kimberly P. Newton Haruna S. Feldman Christina Chambers Laura Wilson Cynthia Behling and 95 more Jeanne M. Clark Jean P. Molleston Naga Chalasani Arun J. Sanyal Mark Fishbein Joel E. Lavine Jeffrey B. Schwimmer Stephanie H. Abrams Sarah E. Barlow Ryan Himes Rajesh Krisnamurthy Leanel Maldonado Rory Mahabir April Carr Kimberlee Bernstein Kristin Bramlage Kim M. Cecil Stephanie DeVore Rohit Kohli Kathleen D. Lake Daniel J. Podberesky Alexander J. Towbin Stavra A. Xanthakos Daniela Allende Srinivasan Dasarathy Arthur J. McCullough Mangesh Pagadala Rish K. Pai Cha'Ron Winston Gerald Behr Joel E. Lavine Jay H. Lefkowitch Ali Mencin Elena Reynoso Manal F. Abdelmalek Mustafa R. Bashir Stephanie Buie Anna Mae Diehl Cynthia D. Guy Christopher Kigongo David Malik Yi‐Ping Pan Dawn Piercy Mariko Kopping Tyler Thrasher Adina Alazraki Rebecca Cleeton María Cordero Albert Altés Saul J. Karpen Jessica Cruz Muños Nicholas Raviele Miriam B. Vos Molly Bozic Naga Chalasani Oscar W. Cummings Samer Gawrieh Ann Klipsch Jean P. Molleston Emily Ragozzino Linda Ragozzino Kumar Sandrasegaran Girish Subbarao Raj Vuppalanchi Laura Walker Kimberly Kafka Ann O. Scheimann Joy Ito Mark Fishbein Saeed Mohammad Cynthia K. Rigsby Lisa Sharda Peter F. Whitington Sarah E. Barlow Theresa Cattoor Jose Derdoy Janet Freebersyser Ajay K. Jain Debra King Jinping Lai Pat Osmack Joan Siegner Susan D. Stewart Brent A. Neuschwander‐Tetri Susan Torretta Kristina Wriston F. Assadian Vanessa Barone Maria Cardona Gonzalez Jodie Davila Oren K. Fix Kelly Anne Hennessey Kris V. Kowdley Katherine I. López Erik Ness

10.1016/j.jpeds.2017.03.007 article EN The Journal of Pediatrics 2017-03-30
Coming Soon ...